Literature DB >> 2572267

Pattern of expression of c-erbB-2 oncoprotein in human fetuses.

P Quirke1, A Pickles, N L Tuzi, O Mohamdee, W J Gullick.   

Abstract

The pattern of expression of the c-erbB-2 oncoprotein was investigated in whole mount preparations of 11 human fetuses by immunocytochemistry using two polyclonal antibodies, 20N and 21N. c-erbB-2 was widely expressed within all three germ layers. Expression remained relatively constant in epithelial, mesodermal and extraembryonic tissues, but varied over time during the development of the fetal skeleton. Western blotting failed to detect c-erbB-2 in normal fetal tissues but did confirm expression in a microvillous membrane preparation of placenta. c-erbB-2 expression is widespread in the human fetus and occurs at an earlier stage than epidermal growth factor receptor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2572267      PMCID: PMC2247351          DOI: 10.1038/bjc.1989.221

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  34 in total

1.  Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector.

Authors:  R Bernards; A Destree; S McKenzie; E Gordon; R A Weinberg; D Panicali
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

2.  Stage- and tissue-specific expression of the neu oncogene in rat development.

Authors:  Y Kokai; J A Cohen; J A Drebin; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  Expression of the c-erbB-2 protein in normal and transformed cells.

Authors:  W J Gullick; M S Berger; P L Bennett; J B Rothbard; M D Waterfield
Journal:  Int J Cancer       Date:  1987-08-15       Impact factor: 7.396

4.  Sporadic amplification of the HER2/neu protooncogene in adenocarcinomas of various tissues.

Authors:  M Tal; M Wetzler; Z Josefberg; A Deutch; M Gutman; D Assaf; R Kris; Y Shiloh; D Givol; J Schlessinger
Journal:  Cancer Res       Date:  1988-03-15       Impact factor: 12.701

5.  Activated neu oncogene sequences in primary tumors of the peripheral nervous system induced in rats by transplacental exposure to ethylnitrosourea.

Authors:  A O Perantoni; J M Rice; C D Reed; M Watatani; M L Wenk
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

6.  Abnormalities of protooncogenes in non-small cell lung cancer. Correlations with tumor type and clinical characteristics.

Authors:  M J Cline; H Battifora
Journal:  Cancer       Date:  1987-12-01       Impact factor: 6.860

7.  Characterization of the promoter region of the human c-erbB-2 protooncogene.

Authors:  S Ishii; F Imamoto; Y Yamanashi; K Toyoshima; T Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

8.  Association of multiple copies of the c-erbB-2 oncogene with spread of breast cancer.

Authors:  D Zhou; H Battifora; J Yokota; T Yamamoto; M J Cline
Journal:  Cancer Res       Date:  1987-11-15       Impact factor: 12.701

9.  Expression of ras proto-oncogene proteins in normal human tissues.

Authors:  M E Furth; T H Aldrich; C Cordon-Cardo
Journal:  Oncogene       Date:  1987-03       Impact factor: 9.867

10.  Role of transforming growth factor-beta in the development of the mouse embryo.

Authors:  U Heine; E F Munoz; K C Flanders; L R Ellingsworth; H Y Lam; N L Thompson; A B Roberts; M B Sporn
Journal:  J Cell Biol       Date:  1987-12       Impact factor: 10.539

View more
  10 in total

1.  Structural and functional aspects of the multiplicity of Neu differentiation factors.

Authors:  D Wen; S V Suggs; D Karunagaran; N Liu; R L Cupples; Y Luo; A M Janssen; N Ben-Baruch; D B Trollinger; V L Jacobsen
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

2.  p185neu is expressed in yolk sac during rat postimplantation development.

Authors:  V Knezevic; R Spaventi; L Poljak; N Slade; A Svajger; K Pavelic
Journal:  J Anat       Date:  1994-08       Impact factor: 2.610

3.  Expression of the integrin-linked kinase (ILK) in mouse skin: loss of expression in suprabasal layers of the epidermis and up-regulation by erbB-2.

Authors:  W Xie; F Li; J E Kudlow; C Wu
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

4.  A study of HER-2/neu expression and silver binding nucleolar organizer regions (Ag NORs) in perilesional normal salivary gland tissue.

Authors:  Essam Taher M A Gaballah
Journal:  Saudi Dent J       Date:  2010-02-10

Review 5.  Beyond wavy hairs: the epidermal growth factor receptor and its ligands in skin biology and pathology.

Authors:  Marlon R Schneider; Sabine Werner; Ralf Paus; Eckhard Wolf
Journal:  Am J Pathol       Date:  2008-06-13       Impact factor: 4.307

6.  The long term prognostic significance of c-erbB-2 in primary breast cancer.

Authors:  J Winstanley; T Cooke; G D Murray; A Platt-Higgins; W D George; S Holt; M Myskov; A Spedding; B R Barraclough; P S Rudland
Journal:  Br J Cancer       Date:  1991-03       Impact factor: 7.640

7.  Expression of growth factor receptors in human brain tumours.

Authors:  N L Tuzi; D J Venter; S Kumar; S L Staddon; N R Lemoine; W J Gullick
Journal:  Br J Cancer       Date:  1991-02       Impact factor: 7.640

8.  c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes.

Authors:  W J Gullick; S B Love; C Wright; D M Barnes; B Gusterson; A L Harris; D G Altman
Journal:  Br J Cancer       Date:  1991-03       Impact factor: 7.640

9.  c-erbB-2 positive breast tumours behave more aggressively in the first years after diagnosis.

Authors:  C A Schroeter; C R De Potter; K Rathsmann; R G Willighagen; J C Greep
Journal:  Br J Cancer       Date:  1992-10       Impact factor: 7.640

10.  Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma.

Authors:  R J Gilbertson; A D Pearson; R H Perry; E Jaros; P J Kelly
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.